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Six infants in an Old Order Amish pedigree were observed to be affected with endocrine-cerebro-osteodysplasia (ECO). ECO is a previ-
ously unidentiﬁed neonatal lethal recessive disorder with multiple anomalies involving the endocrine, cerebral, and skeletal systems.
Autozygosity mapping and sequencing identiﬁed a previously unknown missense mutation, R272Q, in ICK, encoding intestinal cell
kinase (ICK). Our results established that R272 is conserved across species and among ethnicities, and three-dimensional analysis of
the protein structure suggests protein instability due to the R272Q mutation. We also demonstrate that the R272Q mutant fails to
localize at the nucleus and has diminished kinase activity. These ﬁndings suggest that ICK plays a key role in the development of
multiple organ systems.Introduction
Protein kinases belong to one of the largest and most func-
tionally diverse gene families in eukaryotes, constituting
approximately 1.7% of all human genes.1 By phosphory-
lating substrates, kinases can direct activity, localization,
and overall function of numerous target proteins. Kinases
are particularly important for signal transduction and coor-
dination of complex cellular functions, as seen with the
mitogen-activatedprotein (MAP) kinases and cyclin-depen-
dent kinases (CDKs), which play a central role in regulating
mammalian cell proliferation and division.2 Altered kinase
activity or abnormal substrate phosphorylation has been
implicated in monogenic diseases—‘‘kinasopathies’’—
including endocrine disorders,3 cancers,4 immunodeﬁ-
ciencies,5 and cardiovascular diseases.6
Inherited skeletal dysplasias or osteochondrodysplasias
are characterized by abnormal development, growth, and
maintenance of the skeleton.7 Manifestations of skeletal
dysplasias range from clinically undetectable to severe
deformities and lethality.7 A group of lethal autosomal-
recessive skeletal dysplasias are the short rib-polydactyly
(SRP) syndromes,8 which include SRP type II or Majewski
Syndrome (MIM: 263520).9
Herein we report a new syndrome, to our knowledge,
comprising osteodysplasia, cerebral anomalies, and endo-
crineglandhypoplasia.Apedigree fromanOldOrderAmish
community was identiﬁed as having six affected infants
with this previously unreported multisystem, neonatal
lethal condition, designated here as the endocrine-cere-
bro-osteodysplasia (ECO) syndrome. Because theOldOrder134 The American Journal of Human Genetics 84, 134–147, FebruarAmish population reportedly have a high degree of consan-
guinity,10 this pedigree was ideal for autozygosity mapping
of the putative molecular defect.11,12
We delineate the clinical features of ECO and report the
ﬁrst mutation, R272Q (c.1305G/A), within ICK, encod-
ing intestinal cell kinase (ICK). Biochemical and immuno-
cytochemical studies indicate function and localization
deﬁcits, implicating ICK as a key player in development
of the central nervous, skeletal, and endocrine systems.
Material and Methods
Patients and Biological Materials
Two families from an Old Order Amish community were referred
for genetic assessment and counseling, and all six affected infants
were examined by one of the authors (V.S.). Photos, blood, and
tissue samples were provided for research purposes, with ethics
approval (from the Ofﬁce of Research Ethics at the University of
Western Ontario) and informed consent from participating
parents. Peripheral blood and skin biopsy for DNA extraction was
collected from ﬁve affected children, three parents, and two unaf-
fected siblings and used for autozygosity mapping. The genealogy
of the families affectedwith thediseasewasprepared through inter-
views and local Amish community records. DNA from umbilical
cord blood and buccal swabs was extracted from 257 ECO-unaf-
fected individuals born into the Old Order Amish community for
determining the mutant-allele frequency in the community.
Autopsies were performed on three patients (IV-1, IV-2, and IV-8
frompedigree) after 33, 29, and 23weeks of gestation, respectively.
Histology
Routine tissue samples including liver, kidney, and central nervous
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for histopathological examination, formaldehyde ﬁxed, parafﬁn
embedded, sectioned, and then stained with hemolysin and eosin.
Neuropathological examination was performed on formalin-ﬁxed
brain and spinal cord of each of the three autopsy patients.
Genotyping
DNA from ﬁve affected infants and ﬁve unaffected parents and
siblings were genotyped for single-nucleotide polymorphisms
(SNPs) with GeneChipMapping 500K Array Set (Affymetrix, Santa
Clara, CA, USA) at the London Regional Genomics Centre. 250 ng
of double-stranded genomic DNA was digested with either Nsp or
Sty, followed by adaptor ligation and PCR ampliﬁcation with
generic primers. PCR products were then puriﬁed, fragmented
with DNaseI, labeled with terminal deoxytransferase, and ﬁnally
hybridized to theMapping 250KNsp or Sty GeneChips. SNP geno-
types were determined with the B-RLMM algorithm implemented
in Affymetrix GTYPE software.
Autozygosity Mapping
Autozygosity (homozygosity) mapping was performed with Agi-
lent GT v2.0 (Agilent Technologies, Santa Clara, CA, USA), which
scans the genome for regions that are identical by descent. SNP
allele frequencies from controls of European descent were used
for estimating the two-point logarithm of the odds (LOD) scores
for each SNP. Location scores, which are the summation of two-
point LOD scores for a block of homozygous SNPs, were then
calculated for providing a relative measure of likelihood that the
region harbors the disease gene.13
Mutation Analysis
Eleven of the 36 positional candidate genes in the linked region
on chromosome 6p were screened by genomic DNA sequencing
in an affected individual, a parent, an unaffected sibling, and
a non-Amish control. Candidate genes from genomic DNA were
PCR ampliﬁed with primer pairs designed for all coding exons
and intron-exon boundaries. All amplicons were then sequenced
with the sequencing platform of the London Regional Genomics
Centre Sequencing Facility.
Cosegregation of the exon7 ICKmutantwith disease in the pedi-
greewas demonstratedwith direct sequence analysis of all available
family members. The target sequence (552 base pairs [bp]) was
ampliﬁed with primers 50 CTC ATT CCA TAC AGT GCC ACA and
30 GAA TTA CAT GCC AAT TTT CAA AG, followed by electropho-
resis puriﬁcation on a 1.5% agarose gel and analysis on a ABI
3730 DNA Sequencer (Applied Biosystems, Mississauga, ON,
Canada). A total of 13 family members, including the affected
individuals, were studied.
SNaPshot and TaqMan assays were used for identifying allele
frequency of the ICK variation in exon 7, c.1305G/A (GI:
156671211), within 257 Old Order Amish controls and 2855
ethnically diverse and healthy non-Amish controls, respectively.
For SNaPshot, which is a rapid allele-speciﬁc genotyping method,
the puriﬁed 552 bp amplicon (with the above primers) was sub-
jected to ddNTP extension (SnaPShot, Applied Biosystems) with
primer 50 CAG TGG GAT CCC AAG AAA C and analyzed by ABI
3730 DNA Sequencer. TaqMan quantitative real-time PCR assays
were performed with an ABI 7900 sequence detection system
(Applied Biosystems) for providing allele discrimination with
PCR primers (forward primer: 50 GCT CCT GAG AGA CAT GCT
TCA; reverse primer: 50 AAG AAA ATG GAA GAA AAC CTG ACT
AGC T) and two allele-speciﬁc TaqMan probes synthesized for
detecting the ICK variation (allele G: 50 VIC-CCC AAG AAA CGA
CCA AC andmutant allele A: 50 FAM-CCA AGA AAC AAC CAA C).The AmericIn Silico Analysis
Conservation of the ICK protein across species was determined
with ClustalW, which is a multiple-sequence-alignment computer
program, by initially creating a phylogenetic tree of the query
sequence.14 Impact of the amino acid mutation (R/Q at residue
272) on ICK protein structure, function, and pathological implica-
tion was predicted with four online tools, namely PMUT,15
PolyPhen,16 SNPs3D,17 and SIFT.18
The crystal structure of human CDK2 in complex with isopente-
nyladenine (PDB ID: 2EXM), solved by Schulze-Gahmen et al.19,
was used as a basis for modeling the ICK with and without the
R/Q mutation at residue 272. For mimicking ICK, 2EXM was
substituted at A183P and I186V. The resulting structure was visual-
ized in the program PyMOL (v0.99, DeLano Scientiﬁc, San Fran-
cisco, CA, USA).20 With the Rosetta Design program,21 used for
approximating the change in potential energy (in kilocalories) of
the ICK structure with the R/Q mutation, side chains of nearby
contacting amino acids were allowed to vary in conformation.
Change in energy values (in kilocalories) was replicated in Eris
server, which is a protein-stability prediction server that calculates
the change in protein stability caused by mutations.22 Eris server
has the added feature of allowing backbone motion of the amino
acids, which is crucial for protein-stability estimation of small-to-
large mutations.
Plasmids and Cell Culture
TheUltimateORFCloneofhuman ICK cDNA(clone ID: IOH38087)
was provided in the Gateway entry vector, pENTR221, containing
a kanamycin-resistance cassette (Invitrogen, Carlsbad, CA, USA).
The R/Q mutation was introduced into the wild-type ICK clone
within pENT221 in vitro with the GeneTailor Site-Directed Muta-
genesis System(Invitrogen).WithClonase II (Invitrogen) for aiding
homologous recombination, the wild-type and mutant ICK cDNA
was cloned directionally into the Gateway destination vector,
pcDNA-DEST53, containing an N-terminal green ﬂuorescent
protein (GFP) tag and neomycin-resistance cassette. All clones
were sequence veriﬁed. The plasmid pcDNA/GW-53/CAT, which
contained an N-terminal GFP tag, neomycin-resistance cassette,
and chloramphenicol-acetyltransferase (CAT) cassette, was pro-
vided as a vector control. HEK293 cells were maintained at 37C
and5%CO2 inDulbecco’smodiﬁedEagle’smedium(GIBCO,Carls-
bad, CA, USA) supplemented with 10% fetal bovine serum.
Immunocytochemistry
For assessing nuclear localization of ICK constructs, HEK293 cells
were grownoncoverslips in six-well 35mmdishes to 60%–70%con-
ﬂuency, followedby transfectionwith eitherwild-type (WT), R272Q
mutant ICK-expression plasmid, or control vector containing
a CAT cassette (4 mg DNA) by a calcium-phosphate-based method.
48 hr after transfection, cells were washed two times with PBS,
ﬁxed with 4% paraformaldehyde, and stained with Hoechst dye
(2.5 mg/ml in PBS) (Sigma-Aldrich, Oakville, ON, Canada) on ice for
20 min. Cells were then washed three times with PBS andmounted
on glass slideswith PermaFluor AqueousMountingMedium (Fisher,
Markham, ON, Canada). Images were captured with FITC and
UV ﬁlter sets and 403 objective with a Leica (Deerﬁeld, IL, USA)
DMI6000B inverted ﬂuorescence microscope, followed by image
acquisition with the Leica Application Suite (LAS v. 2.8.1).
Protein Quantiﬁcation
HEK293 cells were grown in 225 cm2 ﬂasks until 60%–70% conﬂu-
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expression constructs of either WT, R272Q mutant, or control
vector containing a CAT cassette (96 mg DNA) by a calcium-phos-
phate-based method. 48 hr after transfection, cells were harvested
in ice-cold PBS and lysed in lysis buffer (20 mmol/L Tris-HCl [pH¼
7.4], 50 mmol/L NaCl, 1 mmol/L EDTA, 1 mmol/L EGTA, 1%
Triton X-100, 25 mmol/L NaF supplemented with phosphatase
and protease inhibitors). The lysate was cleared by centrifugation.
Cell lysates were precleared with immobilized protein-G beads
(Fisher) for 3 hr at 4C and then incubated with anti-GFP (3 mg)
for 2 hr at 4C, followed by incubation with immobilized
protein-G beads (Fisher) overnight at 4C. The beads were washed
extensively with lysis buffer and then divided for immunoblotting
and kinase assay.
GFP-immunoprecipitated beads of all three constructs were
boiled in the SDS loading buffer for 5 min. Proteins were then
resolved by 12% SDS-PAGE and transferred onto polyvinylidene
diﬂuoride membranes (Invitrogen). The membranes were blocked
in TBS containing 0.1% Tween-20 and 5% fat-free dry milk for
1 hr and then incubated with anti-ICK (1:200, Santa Cruz
Biotechnology, Santa Cruz, CA, USA) overnight at 4C. The
membrane was then incubated with horseradish peroxidase-
conjugated anti-goat secondary antibodies (1: 50,000, Santa
Cruz Biotechnology) for 1 hr, followed by ICK protein visualiza-
tion with enhanced chemiluminescence-detection Luminol
reagent according to the manufacturer’s instructions (Santa
Cruz Biotechnology).
Kinase Assays
For assessing kinase activity, GFP-immunoprecipitated WT ICK,
R272Q mutant ICK, and vector control were washed extensively
in kinase assay buffer (50 mMHEPES [pH 7.5], 10 mMMgCl2, sup-
plemented with 5 mM DTT, protease inhibitors and phosphatase
inhibitors). The samples were then incubated with 5 mCi [g-32P]
ATP, 100 mM ATP, and 5 mg puriﬁed myelin basic protein (MBP)
(Millipore, Billerica, MA, USA) at 30C for 15 min in 50 ml kinase
assay buffer. As a positive control, active MAPK 2 (Millipore) was
incubated with 5 mCi [g-32P] ATP, 100 mM ATP, and 5 mg MBP at
30C for 10 min in 25 ml kinase assay buffer. Proteins in the reac-
tion were separated by 15% SDS-PAGE. The gels were dried, and
32P was detected by autoradiography.
Statistical Analysis
Immunoﬂuorescence localization data were analyzed with Pear-
son’s chi-square test with SAS v9.1 (SAS Institute, Cary, NC, USA).
Results
Clinical and Pathological Features of ECO
Three affected individuals from twoOldOrder Amish fami-
lies were originally reported as having a Majewski-hydrole-
thalus phenotype in 2004 (S. Bakker and V. Siu, 2004, Am.
Soc. Hum. Genet., abstract). Three further infants were
subsequently born, and the phenotype was further charac-
terized (Figure 1A and Table 1).
The infants have had a high birth weight (90th percen-
tile)23 in four out of six times that this was measured.
Some of the excess weight may be attributed to the excess
ﬂuid associated with severe hydrocephalus. In all of the
pregnancies in which antenatal ultrasound was performed,136 The American Journal of Human Genetics 84, 134–147, Februarmultiple anomalies including ventriculomegaly, cleft lip,
and shortened limbs were observed in the second
trimester. Polyhydramnios occurred in one pregnancy.
Spontaneous onset of labor occurred in two of the preg-
nancies at 33–34 weeks gestation. One infant (IV-1)
showed no spontaneous respirations at birth, was intu-
bated for a day, then extubated and taken home for pallia-
tive care. He died on day 3. The second infant (IV-7) had
severe hydrocephalus, requiring drainage of 350ml of cere-
brospinal ﬂuid from the ventricles to enable vaginal
delivery. The baby died during birth. The other pregnan-
cies were induced between 23 and 29 weeks gestation
because of the severity of the malformations. Integrated
prenatal screening was undertaken in one pregnancy and
was screen positive for increased risk of Trisomy-21, with
a low unconjugated estriol of 0.18 MoM and a low alpha-
fetoprotein of 0.48 MoM. Adrenal hypoplasia found in
this infant (IV-8) may potentially account for the low
prenatal estriol levels.
The face shows awide nasal bridge and ﬂattened nasal tip
with median cleft lip in four of the six cases and a small
premaxilla with bilateral cleft lip and palate in the remain-
ing two cases. There is swelling of the tissue derived from
themaxillary prominences. The eyes are small and sunken,
witha cystic componentobserved in twocases.As expected,
the eyelids were fused in the three infants born between
23 and 25 weeks gestation, but they were also fused in the
infant born at 29 weeks (eyelids normally remain fused
until approximately 26 weeks gestation)23. Ears show
varying degrees of dysplasia. The lower lip is deﬁcient later-
ally, and the chin is small. One infant (IV-2) had two
congenital supernumerary teeth at 29 weeks gestation.
The upper limbs are markedly shortened, with a charac-
teristic bowing of the forearms, ulnar deviation of the
hands, and postaxial polydactyly. X-rays reveal angulation
of the diaphyses. Palmar creases are abnormal. Usually the
index ﬁngers have only one interphalangeal crease,
whereas the other digits lack at least one, if not both, inter-
phalangeal creases. There is severe brachydactyly of the
digits on the hands, as well as syndactyly involving various
combinations of digits two to six. The hips are abducted,
with the thighs held at 90 degrees to the lower legs. There
is a very wide gap between the halluces and the second
toes, reminiscent of atelosteogenesis type 2. On X-rays,
the proximal metaphyses of the femur and tibia are
widened. Overall, the radiologic ﬁndings are most consis-
tent with a diagnosis of Majewski syndrome.
Chest tends to be broad, with widely spaced nipples only
in patient IV-1. No congenital heart defect was found in
any of the three autopsies. The adrenal glands were hypo-
plastic in two cases and absent in one case.
Four genotypic males have all had varying degrees of
abnormal differentiation of the external genitalia. Patient
IV-7, born at 34 weeks, had apparent sex reversal, with
unfused urogenital folds and microphallus. Position of
the urethral oriﬁce was not determined, and no autopsy
was done for assessing for testes. Patients IV-1, IV-2, andy 13, 2009
Figure 1. Clinical and Pathological Findings in ECO Patients
(A) Serial photographs of all six affected individuals (left to right from pedigree) showing full body with polydactyly and micromelia,
craniofacial abnormalities including cleft lip and palate, bowed forearms, wide-gapped hallux (not shown for IV-4 and IV-7), and karyo-
type (top to bottom).
(B) Kidney cortex from patient IV-1 (top left) and medulla from patient IV-2 (top right) show cystically dilated tubules (hematoxylin and
eosin staining [H&E], 403 magnification). Liver sections from the 29-week-gestated patient IV-2 (bottom left) illustrate the persistence
of circular ductal plates (1003 magnification). Squamous metaplasia is seen in the intraprostatic urethra from patient IV-1 (bottom
right) (H&E, 403 magnification).
(C) Representative gross coronal view of the brain of patient IV-1, presenting with absent septum pellucidum, secondary to ventricular
hydrocephalus, and fused thalami due to a lack of the third ventricle.IV-8 hadmicrophallus, hypoplastic scrotumwith no rugae,
prominent scrotal raphe, and bilateral cryptorchidism.
Although the cryptorchidism may not be signiﬁcant in
the context of prematurity (two were delivered at 24 and
28 weeks), IV-1 was delivered at 33 weeks gestation and
had ﬁrst-degree hypospadias. The urethral opening was
present at the tip of the microphallus in the other two
infants. The two genotypic females had unfused urogenital
folds. Born at 24 weeks gestation, IV-3 had unusually
prominent labia majora, whereas IV-4 (25 weeks gestation)
had normal external female genitalia.
Tissue specimens examined from autopsies of patients
IV-1, IV-2, and IV-8 (Figure 1B) showed cystically dilated
tubules to a variable extent in both the medulla and the
cortex of the kidney, as well as persistence of circular ductal
plates in the liver. In addition, patient IV-8 had squamous
metaplasia of the urethra and periurethral glands in the
prostate.The AmericaNeuropathology ﬁndings were extensive, with the main
features being evidence of holoprosencephaly, hypoplastic
or absent corpus callosum, agenesis of the pituitary, and
cerebral cortex malformations. Patients IV-1 (Figure 1C)
and IV-8 had hydrocephalus in the form of ventricular dila-
tation, absence of the third ventricle, dysmorphic septum
pellucidum, and malformed diencephalic elements. It is
conceivable that the apparent overgrowth of the medial
diencephalic structures led to the obliteration of the third
ventricle, initiating secondary hydrocephalus, followed by
the rupture or absence of the septumpellucidum. In patient
IV-2, there is a development of a semilobar holoprosence-
phaly, which indicates an earlier initiation of the genetic
defect resulting in hypertrophic diencephalic elements.
Overall, affected individuals had ventricular hydroceph-
alus, midline cleft lip and palate, abnormal bone develop-
mentmanifesting asmicromelia, bowing of the long bones,
postaxial polydactyly, hypoplastic adrenal and pituitaryn Journal of Human Genetics 84, 134–147, February 13, 2009 137
Table 1. Clinical and Pathological Descriptiona
Clinical Features
Affected Individuals (year of birth)
IV-1 (2004) IV-2 (2005) IV-3 (2005) IV-4 (2006) IV-7 (2002) IV-8 (2003)
Age at delivery (weeks) 33 29 24 25 34 23
Sex male male female female male male
Karyotype 46, XY 46, XY 46, XX 46, XX 46, XY 46, XY
Height40 40 cm
(3rd percentile)
37.3 cm
(10th percentile)
29 cm
(75th percentile)
32.5 cm
(10th percentile)
33.1 cm
(90th percentile)
Weight40 2250 grams
(90th percentile)
1400 grams
(90th percentile)
675 grams
(25th percentile)
897 grams
(90th percentile)
1871 grams
(10th percentile)
667 grams
(90th percentile)
Head circumference40 36.5 cm
(>97th percentile)
31.7 cm
(>97th percentile)
24 cm
(20th percentile)
28 cm
(3rd percentile)
23.3 cm
(90th percentile)
Autopsy þ þ    þ
Oral
Cleft palate midline midline notch in
alveolar ridge
midline midline midline
Cleft lip bilateral median median bilateral median median
Presence of
premaxilla
þ   þ, tiny  
Prominent upper lip
region
 þ  þ  
Hypoplastic/absent
epiglottis
þ  þ
Hypoplastic/absent
larynx
þ  þ
Facial
Midface hypoplasia þ þ þ þ þ þ
Hypoplastic eyes þ þ  þ present; right:
hypoplastic, left:
cystic
cystic
Retinal dysplasia   þ, cataracts
Deep-set eyes þ þ þ þ þ
Fused eyelids þ þ þ þ
Hypotelorism þ
Flat and wide nasal
bridge
þ þ þ þ þ þ
Dysplastic and
low-set ears
þ þ dysplastic þ þ
Micrognathia þ þ þ þ þ þ
Excess skin below
chin
þ þ   þ þ
Teeth  two in lower jaw    
Skeletal
Dolicocephalic  þ   þ þ
Prominent xyphoid  þ    
Polydactyly
(postaxial)
4 limbs 4 limbs 3 limbs 3 limbs 3 limbs 4 limbs
Syndactyly þ þ þ þ þ þ
Brachydactyly þ þ þ þ þ þ
Single transverse
palmar crease
unilateral bilateral unilateral
Ulnar deviation of
hands
þ þ þ þ þ þ
Bowing of forearms
(radius and ulna)
þ þ þ þ þ þ
Bowing of lower
legs (fibula and tibia)
þ     þ
Hitch-hikers’
thumbs
     unilateral
Abducted hips þ þ þ þ þ þ
Wide gap between
first and second toe
þ þ unilateral-right þ þ þ
Talipes equinovaris      
Chest width broad with
wide-spaced nipples
   narrow 138 The American Journal of Human Genetics 84, 134–147, February 13, 2009
Table 1. Continued
Clinical Features
Affected Individuals (year of birth)
IV-1 (2004) IV-2 (2005) IV-3 (2005) IV-4 (2006) IV-7 (2002) IV-8 (2003)
Micromelia þ þ þ þ þ þ
bRadiography
Abnormal long
bones (radius, ulna,
tibia, fibula)
short diaphysis
Short and incurved
ulnae
þ
Short and ovoid
tibiae
þ
Abnormal humerus short diaphysis
Abnormal femur short and ovoid
Abnormal Ilium þ
Abnormal/
hypoplastic
acetabular roof
þ
Central nervous system
Evidence of
holoprosencephaly
failure of separation
of diencephalic
elements
semilobar,
monoventricular,
fusion of basal
ganglia and thalami
diencephalic
agenesis
Corpus callosum þ agenesis hypoplastic
Absence of septum
pellucidum
þ þ
Hydrocephalus
(ventriculomegaly)
communicating þ
Dysmorphic cerebral
aqueduct
þ stenosis
Olfactory bulbs þ absent
Cerebral cortex
malformation
frontal and
occipital regions
focal polymicrogyria rudimentary
sulcation
Brainstem
malformation
þ þ small brainstem
Cerebellar
abnormalities
hemorrhagic,
dysmorphic
peduncles
small cerebellum
Hippocampus
agenesis
þ þ
Leptomeningeal
glioneruronal
heterotopia
þ
Spinal cord
malformation
þ 
Endocrine system
Pituitary gland absent not identified
Adrenal glands hypoplastic absent hypoplastic
Other
Pulmonary
hypoplasia
þ
Gastrointestinal
anomalies
tube-like stomach small stomach 
Squamous
metaplasia
of bladder
þ  
External genitalia microphallus,
hypoplastic scrotum
microphallus,
hypoplastic scrotum
normal normal sex reversal;
hypoplastic
labia majora
present,
microphallus
Cryptorchidism  bilateral    
Polyhydramnios     present 
Note: Blank cells indicate that information was unavailable.
a Information gathered from attending-physician reports.
b Report from International Skeletal Dysplasia Registry (Cedars-Sinai Medical Center) for Patient IV-1.The American Journal of Human Genetics 84, 134–147, February 13, 2009 139
glands, and ambiguous genitalia. Many of the malforma-
tions observed involve a defect of apoptosis, especially the
cleft lip and palate, syndactyly, prolonged persistence of
fusion of the eyelids, and unfused urogenital folds.
Autozygosity Mapping of a Candidate Locus
on Chromosome 6p
Pedigree analysis (Figure 2) of affected individuals revealed
that the syndrome followed an autosomal-recessive inher-
itance pattern, with two parental consanguineous matings
(III-1 with III-2 and III-3 with III-4). Genome-wide auto-
zygosity mapping performed on ﬁve ECO-affected infants
and three of the four parents from the pedigree unambig-
uously mapped ECO to 6p12.2–p12 with a location score
of 462, the summation of two-point LOD data,13,24 which
spans over 1.8 Mb of the chromosome (Figure 3A). This
region in chromosome 6p is bound by SNPs rs2397061
and rs627217 and is comprised of 397 genotyped
Figure 2. SNP-Based Genotyping of ECO-Affected Pedigree Identified a Homozygous Region in Chromosome 6p
ECO in a consanguineous Old Order Amish pedigree. The inheritance of the disease follows an autosomal-recessive mode of transmission.
Affected individuals are shown as blackened squares (male) and circles (female). Diagonal lines across symbols indicate deceased indi-
viduals. A consanguineous marriage is shown by a double line between two individuals. Confirmation of autozygosity-based linkage was
performed by observing the SNP-based genotyping within the candidate region on 6p12.2–p12. A portion of the homozygous region
within patients is shown in boxes. The ICK variation at the coding sequence 1305 (G/A, accession number: NM_016513) that causes
a R/Q change at residue 272 in the protein was analyzed (see Figure 3C for more details) and highlighted in red. Horizontal dashes
above symbols indicate individuals who underwent DNA analysis, and hyphens indicate nongenotyped markers.140 The American Journal of Human Genetics 84, 134–147, February 13, 2009
contiguous SNPs (Figure 3B). Autozygosity-based linkage
was conﬁrmed by haplotype analysis of the SNP genotypes
within the candidate region at chromosome 6p (Figure 2).
Identiﬁcation of the Causative Mutation,
R272Q, in ICK
The candidate interval harbored a total of 36 known and
hypothetical genes.We prioritized sequencing of candidate
genes on thebasis of the following criteria: (1) gene involve-
ment in other single-gene disorders, (2) the role and tissue
speciﬁcity of the encoded protein, and (3) the number of
exons per gene, for feasibility reasons. On the basis of this
priority list, exons of 11 candidate genes were directly
sequenced from the genomic DNA of one of each of the
following: affected individuals, unaffected siblings,
parents, and non-Amish controls. This sequencing led to
the discovery of numerous DNA sequence variations (Table
S1 available online). In an autosomal-recessive mode of
inheritance, the disease causing the variation would be
due to a homozygous genotype observed only in the
affected individual, and the parent would be an obligate
carrier of the causative allele. The only such variation that
also affected the gene and/or its gene product was in ICK.
The ICK gene, composed of 12 exons, had a nonsynony-
mous nucleotide change c.1305G/A in exon 7 (Figure 3C)
in the DNA of the affected individual. This nucleotide
change results in an amino acid change from arginine to
glutamine at residue 272 (R272Q), which lies within the
nuclear-localization-signal domain of ICK (Figure 3D).
DNA sequencing further demonstrated that this alteration
was homozygous in all ﬁve affected individuals, whereas
the phenotypically unaffected parents and siblings were
heterozygotes, consistent with the predicted autosomal-
recessive pattern of inheritance. Complete linkage of ECO
to the R272Q mutation (at chromosome 6p) within the
pedigree was observed, with a two-point linkage LOD score
of 3.61 (at recombination fraction ¼ 0).
In Silico Analysis Demonstrates R272 to Be Conserved
and Required for Protein Stability
The ICK protein belongs to the CDK subfamily, which is
within the CMGC serine-threonine protein kinase family.1
R272 in human ICK is conserved in the CMGC group of
kinases, which includes the CDK, MAP kinase, glycogen
synthase kinase 3 (GSK3), and CDC-like kinase (CLK) fami-
lies. ICK homologs were identiﬁed across phylogeny,
ranging from Homo sapiens to Candida albicans. Using
ClustalW protein sequence alignment, we observed R272
to be conserved in all 84 knownorthologous ICKhomologs
(a representative set is shown in Figure 4A). The conserva-
tion of R272 suggests that mutations in this amino acid
are not well tolerated, given that it may be involved in
crucial aspects of structure and function. A previous study
of ICK that mutagenized several residues, including R272,
suggested that the arginine is required to create a function-
ally and structurally stable conformation by forming ionic
bonds with glutamic acid at residue 189.25 There is pre-The Americsently no three-dimensional (3D) model of ICK because it
hasnot yet been crystallized.However,CDK2and ICK share
very high amino acid homology within the critical func-
tional domain of interest. For homology-based modeling
of ICK in PyMol,20 the 3D region harboring the nuclear-
localization signal of CDK2 was substituted at only 2 of
the 35 residues (residues 183 and 186). As visualized in
Figure 4B, when arginine is mutated to glutamine, the
bondwith glutamic acid is disrupted such that the glutamic
acid rotates its side chain so that it is no longer buried in the
protein but becomes surface exposed, suggesting a cause for
protein instability. Instability was conﬁrmed with thermo-
dynamic values acquired from Rosetta21 and Eris,22 two
discrete protein-structure programs. Both Rosetta and Eris,
which predict protein-packing energy changes, predicted
that the R272Q mutant protein was less stable (by 5.1 and
3.4 kCal/mol, respectively) compared to the wild-type
protein. In addition, four different bioinformatic programs
predicted adeleterious effect of R272Qmutationon the ICK
protein (‘‘pathological,’’ ‘‘probably damaging,’’ ‘‘affected
protein function,’’ and ‘‘deleterious’’ from PMUT, Poly-
Phen, SIFT, and SNPs3D, respectively).
Mutation Screening in Amish and Non-Amish
Populations Suggests R272Q to Be a Private Mutation
The frequency of the A allele in ICK at exon 7, c.1305
G/A, was assessed within members in the Old Order
Amish community as well as individuals from other ethnic
groups. Genotype analysis of 257 healthy Old Order
Amish controls demonstrated no AA homozygote but
identiﬁed ﬁve heterozygote GA carriers outside the ECO-
affected family. The A allele frequency in the Old Order
Amish community was 0.97%; thus, ~1 in 10,000 Old
Order Amish subjects would be predicted to have the
AA genotype. TaqMan-based genotyping of the ICK muta-
tion in an additional 2855 individuals from six ethnic
groups demonstrated the complete absence of the A allele,
indicating that this mutation was speciﬁc to the Amish.
Nuclear Localization Affected by ICK R272QMutation
GFP-tagged ICK wild-type overexpressed in HEK293 cells
localized predominately to the nucleus, whereas the GFP-
tagged ICK R272Q mutant localized predominantly to
the cytoplasm (Figure 5A). Therefore, this single R272Q
point mutation was sufﬁcient to cause a loss of nuclear
localization. Statistical evidence in a bar graph is provided
in Figure S1.
Loss of Kinase Activity of ICK with R272Q Mutation
We studied kinase activity in the presence of the R272Q
mutation. GFP-labeled ICK wild-type and R272Q mutant
were overexpressed in HEK293 cells prior to isolation via
immunoprecipitation, and subsequent kinase-activity
assays were performed for phosphotransferase activity.
Incorporation of 32P into the exogenous substrate, MBP,
was catalyzed by ICK wild-type, but no such incorporation
was detected in the presence of the ICK R272Q mutant
(Figure 5B). The lower panel for Figure 5B indicates thatan Journal of Human Genetics 84, 134–147, February 13, 2009 141
Figure 3. Autozygosity Mapping of ECO-Affected Pedigree Identified an Amino Acid Change, R272Q, in ICK
(A) Autozygosity mapping with SNP genotypes from 500,000 SNP microarrays across the chromosomes (x axis) yielded SNP haplotype
location scores (y axis), with the highest peak on chromosome 6. Location score is the summation of the point LOD scores representing
the likelihood of observing contiguous homozygosity in all five affected individuals of each SNP within the region of homozygosity.13
(B) Expanded view of the candidate locus shows the peak to be on chromosome 6p12.2–p12 (indicated by a star), which is defined by SNPs
rs2397061 and rs627217 and consists of 36 candidate genes, including ICK (indicated in red with a star), distributed over 1.8 Mb of the
genome. Transcriptional direction is indicated by arrowheads.
(C) The genomic structure of ICK gene consists of 12 coding exons with a nonsynonymous nucleotide change in exon 7 (indicated in red
with a star) that alters the amino acid of arginine to glutamine at residue 272 (R272Q). DNA sequence analysis of ICK exon 7 from genomic
DNA of a normal (I, top left tracing) individual, an affected (II, top right tracing) individual, and a R272Q heterozygote (bottom middle
tracing). For each tracing, a normal nucleotide sequence is shown in the top line of letters, with single-letter amino acid codes and codon
numbers beneath. The position of the mutated nucleotides is indicated by the star.142 The American Journal of Human Genetics 84, 134–147, February 13, 2009
Figure 4. ICK Protein Analysis Demonstrates that R272 Is Highly Conserved and that the R272Q Mutation Alters Protein
Structure
(A) Multiple alignments demonstrate that R272 residue is highly conserved across a representative set of species-specific ICK homologs. A
ClustalW analysis of the ICK region encompassing the mutation site at residue 272 (highlighted in red) in aligned homologs with multiple
divergent sequences is shown. The residues shaded in blue indicate amino acids that are similar between homologs.
(B) A magnified look at the 3D region surrounding residue 272 in ICK according to PyMOL modeling, such that the normal (I) protein is
superimposed on the R272Q mutant (II) protein. This modeling predicts that the arginine (Arg, in red) and glutamic acid (Glu, in blue)
form an ionic pair because of close proximity, in normal or wild-type protein (indicated by I). By comparison, the R272Q mutant (indi-
cated by II) is a basic polar to neutral polar substitution and predicts a change in structure such that the glutamine (Gln, in orange) and
glutamic acid (Glu, in orange) can no longer ion pair, leaving the glutamic acid exposed to the surface of the protein rather than buried
within the 3D structure.equal amounts of ICK protein were assayed for kinase
activity. Bands for the ICK constructs were observed speciﬁ-
cally, providing solid evidence for speciﬁcity of the ICK anti-
body. Overall, the assay for 32P incorporation suggests that
the R272Qmutation signiﬁcantly impairs kinase activity.
Discussion
Rare congenital disorders provide new information on the
biological pathways in human organogenesis.26 We reportThe Americain an Old Order Amish community a previously unidenti-
ﬁed and phenotypically distinct syndrome, ECO, whose
clinical manifestations occur early in development and
include dysplasias of skeletal, cerebral, and endocrine
systems resulting in neonatal mortality. In affected
patients, we identiﬁed a homozygous missense mutation,
R272Q, in the kinase ICK. R272 was highly conserved
across species and kinase family members. Moreover, the
protein carrying the mutation was predicted to change
the conformation of the structure, as visualized in PyMol,
and to cause protein instability, as predicted by the(D) The domain structure of ICK protein consists of the protein serine-threonine kinase catalytic domain, a catalytic loop, two activation
loops, two nuclear-localization-signal sites, and a proline-rich region, from the N-terminal to C-terminal end. The amino acid (aa)
272 (indicated in red) lies within the nuclear-localization signal (indicated with a star).n Journal of Human Genetics 84, 134–147, February 13, 2009 143
Figure 5. Altered Subcellular Localiza-
tion and Protein Activity of the R272Q
ICK Mutation
(A) Subcellular localization of wild-type
and mutant ICK is mainly nuclear and cyto-
plasmic, respectively. HEK293 cells were
transfected for 48 hr with wild-type ICK
(ICK WT), mutant ICK (ICK R272Q), or
vector control tagged with GFP and
analyzed by immunofluorescence micros-
copy at 403 magnification. Transfected
cells were identified by GFP fluorescence
(green), and nuclei were stained with
DAPI (blue). The signals obtained for
DAPI and GFP are shown separately (rows
1 and 2), and an overlay of both fluores-
cence signals with differential interference
contrast (DIC) is shown in row 3. We
counted 502, 501, and 501 transfected
cells per construct of wild-type ICK, mutant
ICK, and control, respectively. The differ-
ence in subcellular localization is statisti-
cally significant (chi-square p value ¼
3.9 3 1097), such that the wild-type and
the mutant ICK protein localizes in the
nucleus of 71.9% and 9.78% of the trans-
fected cells, respectively. In addition,
blinded counting was performed in a small
subset of the whole, and the overall results
of the much larger cell numbers were repre-
sentative of this blinded sample.
(B) In vitro kinase assays were performed
with MBP as substrate with anti-GFP immu-
noprecipates obtained from HEK293 trans-
fected cells and active-purified ERK2 as
a positive control (top panel). HEK293
cells were transfected for 48 hr with GFP-
tagged ICK WT, ICK R272Q, or vector
control followed by anti-GFP immunopre-
cipitation. Bar graphs indicate means 5
standard deviations from three sets of
experiments, showing the relative kinase activities normalized to vector control quantitated by densitometry. The autoradiograph shows
results of one experiment demonstrating incorporation of 32P into MBP. The upper blot shows results of a representative experiment
demonstrating the levels of MBP phosphorylation. The lower blot, developed with anti-ICK, demonstrates equal amounts of ICK WT
and ICK R272Q.change in energy values in the programs Rosetta Design
and Eris. The R272Q mutation impairs nuclear localiza-
tion and kinase activity. The ICK R272Q mutation under-
lying the ECO syndrome implicates intestinal cell kinase
as central to the development of several organ systems
in humans.
Although ECO is, to our knowledge, a distinct new
syndrome, it does share some clinical features with previ-
ously reported syndromes, such as Majewski syndrome
and hydrolethalus. Majewski syndrome, described in
1971, maps to chromosome 4 and is a lethal form of
neonatal dwarﬁsm characterized by short ribs, microme-
lia, polysyndactyly, median cleft lip, polycystic kidneys,
ambiguous genitalia, and hypoplastic epiglottis, larynx,
and lungs.27 Hydrolethalus, described in 1981, maps to144 The American Journal of Human Genetics 84, 134–147, Februarchromosome 11q24.2 and is a neonatal lethal auto-
somal-recessive syndrome characterized by multiple
congenital anomalies including hydramnios,
hydrocephalus, a ‘‘keyhole’’ defect of the occipital bone,
low-set ears, and midline malformations, such as heart
and brain defects, cleft lip or palate, an abnormally shaped
nose or jaw, incomplete lung development, and abnormal
genitalia.28 The causative genes for both Majewski
syndrome and hydrolethalus have yet to be identiﬁed,29
but neither locus overlaps with 6p12.2–p12 harboring
ICK. A transitional clinical condition, pseudotrisomy 13
(MIM 264480), consists of characteristics found in both
Majewski syndrome and hydrolethalus, including holo-
prosencephaly, hydrocephalus, polydactyly, heart defects,
and facial anomalies consistent with the trisomy 13y 13, 2009
Figure 6. Schematic of Overlapping Features between Six Disorders, including ECO
The grid shows organ-system involvement, with darkened cells indicating the presence of the subphenotype for each disease. Prevalence
of disorder is in a white-to-black gradient system in which a frequency of 0% is white, 50% is gray, and 100% is black. The reordering of
the disorders was the result of hierarchical cluster analysis that clustered the disease on the basis of similarities in organ-system involve-
ment. The diseases included are (from top to bottom) Hydrolethalus, Pseudotrisomy 13, Majewski Hydrolethalus, Mohr-Majewski, Majew-
ski syndrome, and ECO (highlighted in red).condition without any chromosomal defects.30 Another
clinical condition that bears some similarity to Majewski
syndrome and hydrolethalus was reported in 1992,
uniting two distinct genetic conditions such that the
two conditions are suspected to be causally related.31 ‘‘Ma-
jewski hydrolethalus’’ was characterized by short limbs
and ribs and abnormal tibiae consistent with Majewski
syndrome as well as hydraminos, hydrocephalus, and
keyhole-shaped occipital bone consistent with hydrole-
thalus syndrome.32 Again, the causative gene is unknown.
Another distinct yet related condition with an unknown
causative gene is the autosomal-recessive Mohr-Majewski
syndrome (MIM: 258860).33
Hierarchical cluster analysis reordered these six related
diseases on the basis of clinical features such that ECO
had the closest clinical description to the Majewski and
Mohr-Majewski syndromes (Figure 6). However, Majewski
and Mohr-Majewski have the presence of short ribs and
cardiac defects, respectively, which are features that are
not observed in ECO-affected infants. Despite the absence
of overlap of loci from mapping studies, DNA sequencing
of ICK in individuals with Majewski and hydrolethalus
syndromes might help to establish whether these disorders
are allelic or whether ECO truly represents a distinct and
unique disorder.
ICKwas initially cloned from the human intestinal crypt
with degenerate primers speciﬁc for MAP kinases.34,35 The
designation ICK appears to be a misnomer, given that ICK
is ubiquitously expressed in adult human tissues.34,35
Alternatively, this protein has sometimes been called
MAK-related kinase (MRK) in previous reports.35,36 ICK
has a variant, ICKb (accession number AAH35807);
however, ICKb is 337 amino acids shorter with an alterna-
tive C terminus, such that ICKb is predominantly in the
cytoplasm.25 ICK shares 38% to 40% identity to the cata-
lytic domains of CDKs, which are involved in cell-cycle
transition, and MAP kinases, regulators of cell-cycle
entry.25 ICK is activated by dual phophorylation of theThe AmericTDY motif (Y-159 and T-157), such that it autophosphory-
lates at Y-159 and can be phosphorylated by human kinase
cell-cycle-related kinase (CCRK), while being deactivated
by protein phosphatase 5 (PP5).37 It may be speculated
that because the residue 272 mutation of ICK prevents
nuclear localization, it hinders phosphorylation of the
ICK by the nuclear-residing CCRK, which is ultimately
required for kinase activity of ICK.
A previous in vitro study of ICK coincidentally mutagen-
ized residue 272 from arginine to alanine (R272A). Like
R272Q, this non-naturally occurring R272A mutant
showed impaired nuclear localization and kinase activity.25
As determined by in vitro studies, ICK can phosphorylate
exogenous substrates, such as myelin basic protein25,36
and Scythe, an antiapoptotic protein required during
mammalian development.38 Scythe (BAT3) is a nuclear
protein that is implicated in apoptosis.39 Scythe knockout
mice display brain heteropia (abnormal migration), hydro-
cephalus, and dilated and hypoplastic kidneys as well as
lung abnormalities, leading to perinatal death.39 In addi-
tion to endocrine hypoplasia, syndactyly, cleft lip, and cleft
palate, ECO-affected infants also develop phenotypes
observed with Scythe deﬁciency. Because ICK is involved
in phosphorylation and activation of Scythe, it is presum-
able that an ICK mutation would include defects observed
with Scythe inactivation. Overall, ICK seems to be involved
in cell-cycle regulation and apoptosis during mammalian
development. Other evidence that ICK has an effect on
embryological development is the observed presence of
ICK mRNA in placental tissue,35 although speciﬁc experi-
ments will need to be performed for conﬁrmation. Previous
work36 has suggested that ICK has a role in development of
the myocardium, but because ECO syndrome is a multior-
gan disorder, this kinase must have a role in development
of other tissues and organ systems. Interestingly, no cardiac
anomalies have been observed in ECO syndrome patients.
Thus, we have characterized a previously unreported
human syndrome—ECO—in which mutated ICK isan Journal of Human Genetics 84, 134–147, February 13, 2009 145
functionally impaired. This single point mutation at
residue 272 not only affects structure, but also function,
such that it can no longer localize properly, which has
detrimental downstream effects and ultimately leads to
abnormal fetal development. These ﬁndings suggest that
ICK plays a key role in the development of multiple organ
systems.
Supplemental Data
Supplemental Data include one table and one ﬁgure and can
be found with this article online at http://www.ajhg.org/.
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